AFF4 and colorectal carcinoma: Overall, our results call attention to the unrecognized potential role of AFF4 in CRC and contribute to the identification of AFF4 as a prognostic biomarker, adding an attractive and challenging therapeutic target to the search for new therapeutic prospects for CRC patients.